News

RELEVANCE: Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance

The new Europea Project is searching for 15 early stage researchers, educate them, and engage into interactive multidisciplinary work within five major topics related to red blood cells

October 27, 2015

ENERCA will collaborate with the new European Project "Regulation of red cell life-span, erythropoiesis, survival, senescence and clearance” (Acronym RELEVANCE), an international consortium of thirteen partners representing academic research centres, diagnostic labs, blood
supply centres, and small industries that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cells production, function, and clearance in healthy humans and patients.

The aim of RELEVANCE is to build a team of 15 early stage researchers, educate them, and engage into interactive multidisciplinary work within five major topics will be addressed within individual work packages:

WP1 - Diagnostic tools on red blood cells;
WP2 - Red blood cells as treatment targets in pathophysiological conditions;
WP3 - Red blood cell interactions with other cells and tissues;
WP4 - Red blood cell transfusions with a focus on storage and conservation of blood donations on the one side and the in vitro production of red blood cells on the other;
WP5 - Red blood cells in exercise and training including aspects of doping
control.

The ESRs will get a chance to spend 3 years in a foreign country as they can only be employed in a state different from the state they lived and worked in for more than 12 months during the past 3 years. Secondments of at least 2 months will be performed with one or more partner groups. Training sessions organised by the teams in Amsterdam, Saarbrucken and Zurich will
introduce the ESRs to novel state-of-art experimental techniques, newest updates in science and medicine, and provide information needed for successful carrier developments in research, medicine or industry in the future.

Candidates should have a master degrees in biology, medicine and bioengineering. Specific information for each of 15 positions may be obtained via the Apply through website:
http://relevance.arivis.com/

About the employer

RELEVANCE brings together the following High Schools, Clinics, and Companies:

Academic research centres:

* Saarland University, Germany
* Sanquin Blood Supply 1 (Dept of Hematopoiesis) and 2 (Dept of Blood
Cell Research), Netherlands
* Biological Station Roscoff (CRNS), France
* INSERM, France
* University Zürich, Switzerland
* University Bristol, United Kingdom
* University of Pavia, Italy
* UMCU, Netherlands

Diagnostic labs:

* Hospital Clínic de Barcelona, Red Cell Pathology Unit (IDIBAPS), Spain

Blood supply centres:

* Sanquin Blood Supply, Department of Hematopoiesis (SB1), Netherlands
* Sanquin Blood Supply, Department of Blood Cell Research (SB2),
Netherlands

Companies:

* Arivis, Germany
* Epigem, United Kingdom
* Optorobotix, Denmark
* Nanion, Germany


Additional information on the project partners including contact details and formal requirements to the candidates employed by the individual partners can be found at the RELEVANCE project web-page via the Apply through website button. Please note, that the starting dates may vary depending on the partner.

Related information

Copyright © 2002 - 2017 Enerca

Co-funded by the Health Programme of the European Union.